LUCAT1 and esophageal squamous cell carcinoma: LUCAT1 dysregulation was observed in various cancers, including non-small-cell lung cancer, glioma, renal cell carcinoma, esophageal squamous cell carcinoma, prostate cancer, cutaneous squamous cell carcinoma, and CRC15–21.